Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannelore Bauer

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
CNS & Neurological Disorders Drug Targets|September 17, 2016
Tight Junctions of the Blood-Brain Barrier - A Molecular GatekeeperHannelore Bauer, Andreas Traweger
Experimental Gerontology|November 25, 2005
Neuronal stem cells in adultsHans-Christian Bauer, Herbert Tempfer, Gustav Bernroider, et al.
Frontiers in Neuroscience|December 19, 2014
"You Shall Not Pass"-tight junctions of the blood brain barrierHans-Christian Bauer, István A Krizbai, Hannelore Bauer, et al.
Antioxidants & Redox Signaling|February 8, 2011
Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinasesChristine Lehner, Renate Gehwolf, Herbert Tempfer, et al.
Journal of Personalized Medicine|January 21, 2023
Lipedema Research-Quo Vadis?Anna M Ernst, Hannelore Bauer, Hans-Christian Bauer, et al.
The Journal of Biological Chemistry|October 31, 2002
The tight junction protein ZO-2 localizes to the nucleus and interacts with the heterogeneous nuclear ribonucleoprotein scaffold attachment factor-BAndreas Traweger, Renate Fuchs, Istvan A Krizbai, et al.
The Journal of Biological Chemistry|January 10, 2002
The tight junction-specific protein occludin is a functional target of the E3 ubiquitin-protein ligase itchAndreas Traweger, Deyu Fang, Yun-Cai Liu, et al.
International Journal of Molecular Sciences|November 6, 2019
The Blood-Brain Barrier and Its Intercellular Junctions in Age-Related Brain DisordersLaura Costea, Ádám Mészáros, Hannelore Bauer, et al.
Current Pharmaceutical Design|July 29, 2016
Pharmaceutical Targeting of the BrainIstván A Krizbai, Ádám Nyúl-Tóth, Hans-Christian Bauer, et al.
Differentiation; Research in Biological Diversity|November 2, 2007
Nuclear Zonula occludens-2 alters gene expression and junctional stability in epithelial and endothelial cellsAndreas Traweger, Christine Lehner, Attila Farkas, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
CNS & Neurological Disorders Drug Targets|September 17, 2016
Tight Junctions of the Blood-Brain Barrier - A Molecular GatekeeperHannelore Bauer, Andreas Traweger
Experimental Gerontology|November 25, 2005
Neuronal stem cells in adultsHans-Christian Bauer, Herbert Tempfer, Gustav Bernroider, et al.
Frontiers in Neuroscience|December 19, 2014
"You Shall Not Pass"-tight junctions of the blood brain barrierHans-Christian Bauer, István A Krizbai, Hannelore Bauer, et al.
Antioxidants & Redox Signaling|February 8, 2011
Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinasesChristine Lehner, Renate Gehwolf, Herbert Tempfer, et al.
Journal of Personalized Medicine|January 21, 2023
Lipedema Research-Quo Vadis?Anna M Ernst, Hannelore Bauer, Hans-Christian Bauer, et al.
The Journal of Biological Chemistry|October 31, 2002
The tight junction protein ZO-2 localizes to the nucleus and interacts with the heterogeneous nuclear ribonucleoprotein scaffold attachment factor-BAndreas Traweger, Renate Fuchs, Istvan A Krizbai, et al.
The Journal of Biological Chemistry|January 10, 2002
The tight junction-specific protein occludin is a functional target of the E3 ubiquitin-protein ligase itchAndreas Traweger, Deyu Fang, Yun-Cai Liu, et al.
International Journal of Molecular Sciences|November 6, 2019
The Blood-Brain Barrier and Its Intercellular Junctions in Age-Related Brain DisordersLaura Costea, Ádám Mészáros, Hannelore Bauer, et al.
Current Pharmaceutical Design|July 29, 2016
Pharmaceutical Targeting of the BrainIstván A Krizbai, Ádám Nyúl-Tóth, Hans-Christian Bauer, et al.
Differentiation; Research in Biological Diversity|November 2, 2007
Nuclear Zonula occludens-2 alters gene expression and junctional stability in epithelial and endothelial cellsAndreas Traweger, Christine Lehner, Attila Farkas, et al.
Pageof 3